TSHA 8-K: SEC filing

Taysha Gene Therapies

Filed with the SEC on Nov 12, 2026 · accession 0001193125-26-456974

TSHA filed a 8-K (current report) with the SEC on Nov 12, 2026. Taysha Gene Therapies reported financial results for the quarter ended September 30, 2026, along with recent business highlights.

Summary of the filing

Taysha Gene Therapies reported financial results for the quarter ended September 30, 2026, along with recent business highlights. The results were furnished via a press release as Exhibit 99.1 to the Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantTaysha Gene Therapies, Inc.

Chief financial officerKamran Alam

✦ Ask GOAX AI about this filing — what it means for TSHA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TSHA?

Click here

Frequently asked questions

What did TSHA file with the SEC on Nov 12, 2026?

TSHA filed a 8-K (SEC filing). Taysha Gene Therapies reported financial results for the quarter ended September 30, 2026, along with recent business highlights. The results were furnished via a press release as Exhibit 99.1 to the Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TSHA SEC filings

Get alerts when TSHA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TSHA overview TSHA analysis TSHA news Latest SEC filings